Compound 1399
Identifiers
- Canonical SMILES:
CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2S(C)(=O)=O)c1c[nH]c2cc(F)ccc12
- IUPAC name:
(2S)-N-[(1S)-2-[(3aR,6S,6aR)-6-(6-fluoro-1H-indol-3-yl)-4-methylsulfonyl-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrol-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide
- InChi:
InChI=1S/C27H38FN5O4S/c1-16(29-2)26(34)31-24(17-7-5-4-6-8-17)27(35)32-12-11-23-25(32)21(15-33(23)38(3,36)37)20-14-30-22-13-18(28)9-10-19(20)22/h9-10,13-14,16-17,21,23-25,29-30H,4-8,11-12,15H2,1-3H3,(H,31,34)/t16-,21+,23+,24-,25+/m0/s1
- InChiKey:
PPYXKCGATRDULW-STRHDHNLSA-N
External links
![]() 45138105 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Stephen M. Condon, Matthew G. Laporte, Tetralogic Pharmaceuticals Corp.. . Iap inhibitors None. | 43 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 7.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 547.26 g/mol | |||
HBA | 9 | |||
HBD | 3 | |||
HBA + HBD | 12 | |||
AlogP | 1.21 | |||
TPSA | 114.61 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2010033531 | 43 | XIAP P98170 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6647 | Anamorelin | DB06645 | |
0.6564 | LTX-315 | DB12748 | |
0.6283 | 2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE) | DB04758 | |
0.6265 | Gramicidin D | DB00027 | |
0.6243 | Omiganan | DB06610 | |
0.6229 | Murepavadin | DB14777 | |
0.6216 | Relamorelin | DB12678 | |
0.6140 | Ilomastat | DB02255 | |
0.6114 | Somatoprim | DB12777 | |
0.6023 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
0.6023 | BQ-123 | DB12054 | |
0.5989 | N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE | DB08489 | |
0.5917 | Macimorelin | DB13074 | |
0.5773 | Tifuvirtide | DB05413 | |
0.5759 | Vapreotide | DB04894 |